Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.

Authors:
Avramis VI; Tiwari PN.

Journal:
Int J Nanomedicine

Publication Year: 2006

PMCID:
PMC2426805

PMID:
17717965

View on PubMed View on PMC
Journal Information

Full Title: Int J Nanomedicine

Abbreviation: Int J Nanomedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nanotechnology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to P…
Sekita A; Unterweger H; Berg S and 11 more (2024) - Transparency Score: 3/6
Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
Xiang D; Zhou L; Yang R and 5 more (2024) - Transparency Score: 3/6
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nan…
Dong Z; Zhang X; Zhang Q and 4 more (2024) - Transparency Score: 3/6
Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression.
Wang M; Lan S; Zhang W and 7 more (2024) - Transparency Score: 3/6
Anticipation and Verification of Dendrobium-Derived Nanovesicles for Skin Wound Healing Targets, Pr…
Tu J; Jiang F; Fang J and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025